TXNIP and type 1 diabetes mellitus: In vivo, type-1 diabetes modeled in rats caused increased TXNIP in peripheral blood along with decreased NO and VEGF, increased ROS, and increased inflammation-associated vascular cell adhesion molecule 1 (VCAM-1) [95].